ArkeaBio, a Boston developer of a vaccine to reduce livestock methane emissions, raised a $26.5 million in venture capital funding led by an investment fund founded by Bill Gates.
top of page
bottom of page
To receive the News You Need in your Inbox, Subscribe HERE
ArkeaBio, a Boston developer of a vaccine to reduce livestock methane emissions, raised a $26.5 million in venture capital funding led by an investment fund founded by Bill Gates.
Comments